Item 5.02. Departure of Directors or Certain Officers, Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 29, 2021, the Compensation Committee of the Board of Directors (the
"Board") of Silo Pharma, Inc. (the "Company"), approved and authorized
compensation, as described below, to its non-employee directors to enable the
Company to attract and retain qualified non-employee directors and in
consideration of their service to the Company (the "Non-Employee Director
Compensation"). The Board approved the following cash payments and option grants
under the Non-Employee Director Compensation: (1) each non-employee director
receives a cash retainer fee of $25,000 and a 5-year option to purchase $25,000
worth of common stock (177,233 shares) with an exercise price of $0.1460,
vesting over the course of one year with 100% vesting on the one-year
anniversary from the date of grant; (2) the Audit Committee Chair receives (in
addition to the compensation set forth in (1) above) an additional cash fee of
$12,500 and (3) the Compensation Committee Chair receives (in addition to the
compensation set forth in (1) above) an additional cash fee of $7,500.
1
© Edgar Online, source Glimpses
SILO PHARMA, INC. 
